Insulin sensitivity at diagnosis of type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67)
Insulin sensitivity at diagnosis of type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67)
Aims: insulin resistance is common in Type 2 diabetes which, in turn, is associated with a markedly increased risk of cardiovascular disease. Whether insulin sensitivity measured after diagnosis of diabetes is associated with incident cardiovascular disease was evaluated in this prospective study.
Methods: three thousand five hundred and eighty-two subjects with newly diagnosed diabetes, recruited to the UK Prospective Diabetes Study (UKPDS), free of cardiovascular disease, and with complete information on insulin sensitivity and potential confounders, were followed prospectively to the first occurrence of (i) fatal or non-fatal myocardial infarction, MI (ii) fatal or non-fatal stroke, and (iii) coronary heart disease, CHD (fatal or non-fatal MI, sudden death or ischaemic heart disease). Insulin sensitivity was measured by Homeostatic Model Assessment (HOMA).
Results: insulin sensitivity as measured by HOMA was not associated with subsequent MI, stroke, or CHD in univariate or multivariate models controlling for age, sex, ethnicity, HbA1c, body mass index, plasma triglycerides, cholesterol and smoking. The hazard ratio associated with a doubling of insulin sensitivity with fatal or non-fatal MI in a multivariate model was 0.92 (95% confidence interval, CI, 0.80-1.05). These results were not changed by the exclusion of overweight patients randomized to metformin.
Discussion: estimation of insulin sensitivity provides no additional useful information with respect to the risk of the first occurrence of cardiovascular disease in patients with newly diagnosed Type 2 diabetes. Among patients with Type 2 diabetes, insulin resistance is not a risk factor for cardiovascular disease.
Cardiovascular disease, Diabetes, Insulin resistance, Prospective
306-311
Adler, A.I.
d02dfdd6-ca6f-4cdc-91ab-8eb79ff94d7f
Levy, J.C.
d9dbe8ca-9ef9-4b2c-b3c1-64ccec04106f
Matthews, D.R.
ba1a878d-6510-45c5-896c-d4ade423caca
Stratton, I.M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Hines, G.
0603b95e-5d9c-45d8-9754-0d9afeb4d571
Holman, R.R.
336fb2f7-edb5-4d65-a7b0-465111cbd047
16 February 2005
Adler, A.I.
d02dfdd6-ca6f-4cdc-91ab-8eb79ff94d7f
Levy, J.C.
d9dbe8ca-9ef9-4b2c-b3c1-64ccec04106f
Matthews, D.R.
ba1a878d-6510-45c5-896c-d4ade423caca
Stratton, I.M.
772f25b9-23c0-4240-a3f6-1e76b03b172f
Hines, G.
0603b95e-5d9c-45d8-9754-0d9afeb4d571
Holman, R.R.
336fb2f7-edb5-4d65-a7b0-465111cbd047
Adler, A.I., Levy, J.C., Matthews, D.R., Stratton, I.M., Hines, G. and Holman, R.R.
(2005)
Insulin sensitivity at diagnosis of type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Diabetic Medicine, 22 (3), .
(doi:10.1111/j.1464-5491.2004.01418.x).
Abstract
Aims: insulin resistance is common in Type 2 diabetes which, in turn, is associated with a markedly increased risk of cardiovascular disease. Whether insulin sensitivity measured after diagnosis of diabetes is associated with incident cardiovascular disease was evaluated in this prospective study.
Methods: three thousand five hundred and eighty-two subjects with newly diagnosed diabetes, recruited to the UK Prospective Diabetes Study (UKPDS), free of cardiovascular disease, and with complete information on insulin sensitivity and potential confounders, were followed prospectively to the first occurrence of (i) fatal or non-fatal myocardial infarction, MI (ii) fatal or non-fatal stroke, and (iii) coronary heart disease, CHD (fatal or non-fatal MI, sudden death or ischaemic heart disease). Insulin sensitivity was measured by Homeostatic Model Assessment (HOMA).
Results: insulin sensitivity as measured by HOMA was not associated with subsequent MI, stroke, or CHD in univariate or multivariate models controlling for age, sex, ethnicity, HbA1c, body mass index, plasma triglycerides, cholesterol and smoking. The hazard ratio associated with a doubling of insulin sensitivity with fatal or non-fatal MI in a multivariate model was 0.92 (95% confidence interval, CI, 0.80-1.05). These results were not changed by the exclusion of overweight patients randomized to metformin.
Discussion: estimation of insulin sensitivity provides no additional useful information with respect to the risk of the first occurrence of cardiovascular disease in patients with newly diagnosed Type 2 diabetes. Among patients with Type 2 diabetes, insulin resistance is not a risk factor for cardiovascular disease.
This record has no associated files available for download.
More information
Accepted/In Press date: 1 March 2004
e-pub ahead of print date: 2 December 2004
Published date: 16 February 2005
Keywords:
Cardiovascular disease, Diabetes, Insulin resistance, Prospective
Identifiers
Local EPrints ID: 487031
URI: http://eprints.soton.ac.uk/id/eprint/487031
ISSN: 0742-3071
PURE UUID: a79eccc8-c1ae-4638-b442-b5e53012c17a
Catalogue record
Date deposited: 09 Feb 2024 17:47
Last modified: 18 Mar 2024 04:01
Export record
Altmetrics
Contributors
Author:
A.I. Adler
Author:
J.C. Levy
Author:
D.R. Matthews
Author:
I.M. Stratton
Author:
G. Hines
Author:
R.R. Holman
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics